Ulrich Farms sold a cow for slaughter with ampicillin residue above tolerance and kept inadequate treatment records.
What happened
FDA inspected Ulrich Farms' dairy operation in Dresser, Wisconsin, on October 6 and 21, 2021. FDA found that a cow sold for slaughter on May 10, 2021 had ampicillin at 0.08 ppm in kidney tissue, above the 0.01 ppm tolerance. FDA also found missing treatment records and extralabel ampicillin use (use not following the approved label) without veterinarian supervision or label directions.
What FDA found
They sold a cow for slaughter whose kidney tissue contained ampicillin at 0.08 ppm, above the 0.01 ppm tolerance.
section 402(a)(2)(C)(ii) of the Act (21 U.S.C. § 342(a)(2)(C)(ii))They lacked an adequate system to keep medicated animals out of slaughter long enough for drug residues to clear.
section 402(a)(4) of the Act (21 U.S.C. § 342(a)(4))They did not keep treatment records showing dose, route, reason for use, milk and meat withdrawal times, and who gave the drug.
section 402(a)(4) of the Act (21 U.S.C. § 342(a)(4))They used ampicillin in ways not on the label without a licensed veterinarian's supervision.
21 CFR 530.11(a)They gave ampicillin for stomach issues even though the label is for bovine respiratory disease and did not follow the label's dosing directions.
21 CFR 530.11(a)The extralabel ampicillin use led to an illegal drug residue.
21 CFR 530.11(c)
What FDA wants
FDA asks Ulrich Farms to notify the agency in writing within 15 working days of receipt of the letter about specific steps taken to correct violations and prevent recurrence, with related documentation. If corrective actions cannot be completed in that time, the company must state the reason and when it will finish.
Who should pay attention
- dairy farms that sell cull cows for slaughter
- slaughterhouses and meat processors receiving dairy cattle
- veterinarians advising livestock producers on drug withdrawal
This is a summary. Read the original letter on fda.gov.